, ,

NRG1 Fusions: The Newest Actionable Target

Faculty: John Strickler, MD
Disclosures

Faculty

John Strickler, MD
Professor of Medicine
Co-leader, Duke Cancer Institute Molecular Tumor Board
Duke University

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading